Feature|Videos|June 25, 2026
Building Long-Term Value Through Functional Service Provider Partnerships
Author(s)Diana Cucos, President FSP 360, Syneos Health
Key Takeaways
- Understand how Syneos Health's FSP model differs from short-term staffing augmentation.
- Follow the logic of building a global talent hub to support continuity in clinical trials.
Diana Cucos, President FSP 360 at Syneos Health, describes their functional service provider (FSP) model and AbbVie partnership, highlighting how execution builds long-term clinical trial value.
The clinical trial industry has a range of staffing approaches, from small providers that offer short-term team augmentation to FSP models built around long-term value creation. Sponsors evaluating these options must weigh not only immediate staffing needs but also how a partner will support process improvement, innovation, and value creation over time. Diana Cucos, President FSP 360 at Syneos Health, describes their FSP approach as one that goes beyond placing a team. They become embedded within a sponsor's operations and work to understand evolving needs. Working with AbbVie, she discusses how the companies selected Spain as a talent destination before expanding to a hub in Latin America, building a global team intended to support continuity in clinical trials. Industry innovation depends on execution, which requires a partner able to integrate new ideas into a sponsor's existing operating model.
Related Content
Trending on Applied Clinical Trials Online
1
Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract
2
Two Decades of Rising Protocol Complexity: A Longitudinal Analysis of Clinical Trial Design Evolution, 2004–2025
3
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
4
ACT Brief: Operation TrialBlazer Launched, Protocol Complexity Rising, and Data Infrastructure for AI
5